Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Martin Stenson, Anders Pedersen, Sverker Hasselblom, Herman Nilsson-Ehle, Bengt Göran Karlsson, Rui Pinto & Per-Ola Andersson. (2016) Serum nuclear magnetic resonance-based metabolomics and outcome in diffuse large B-cell lymphoma patients – a pilot study. Leukemia & Lymphoma 57:8, pages 1814-1822.
Read now
Read now
Bhumsuk Keam, Hyerim Ha, Tae Min Kim, Yoon Kyung Jeon, Se-Hoon Lee, Dong-Wan Kim, Chul Woo Kim & Dae Seog Heo. (2015) Neutrophil to lymphocyte ratio improves prognostic prediction of International Prognostic Index for patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone. Leukemia & Lymphoma 56:7, pages 2032-2038.
Read now
Read now
Chadi Nabhan & Jayesh Mehta. (2012) Diffuse large B-cell lymphoma: is there a place for autologous hematopoietic stem cell transplant in first remission in the era of chemo-immunotherapy?. Leukemia & Lymphoma 53:10, pages 1859-1866.
Read now
Read now
Ranjit S Bindra & Joachim Yahalom. (2011) The important role of radiation therapy in early-stage diffuse large B-cell lymphoma: time to review the evidence once again. Expert Review of Anticancer Therapy 11:9, pages 1367-1378.
Read now
Read now
Articles from other publishers (19)
Abdullah Alfaifi, Mohammed Y. Refai, Mohammed Alsaadi, Salem Bahashwan, Hafiz Malhan, Waiel Al-Kahiry, Enas Dammag, Ageel Ageel, Amjed Mahzary, Raed Albiheyri, Hussein Almehdar & Ishtiaq Qadri. (2023) Metabolomics: A New Era in the Diagnosis or Prognosis of B-Cell Non-Hodgkin’s Lymphoma. Diagnostics 13:5, pages 861.
Crossref
Crossref
Fei Fei, Meihong Zheng, Zhenzhen Xu, Runbin Sun, Xin Chen, Bei Cao & Juan Li. (2022) Plasma Metabolites Forecast Occurrence and Prognosis for Patients With Diffuse Large B-Cell Lymphoma. Frontiers in Oncology 12.
Crossref
Crossref
Mi Mi, Zijian Liu, Xin Zheng, Qiuyue Wen, Fang Zhu, Juan Li, Ishanee Devi Mungur & Liling Zhang. (2021) Serum metabolomic profiling based on GC/MS helped to discriminate Diffuse Large B-cell Lymphoma patients with different prognosis. Leukemia Research 111, pages 106693.
Crossref
Crossref
Lars C. Gormsen, Mikkel H. Vendelbo, Mette Abildgaard Pedersen, Ate Haraldsen, Karin Hjorthaug, Trond Velde Bogsrud, Lars J. Petersen, Karen Juul Jensen, Rasmus Brøndum & Tarec C. El-Galaly. (2019) A comparative study of standardized quantitative and visual assessment for predicting tumor volume and outcome in newly diagnosed diffuse large B-cell lymphoma staged with 18F-FDG PET/CT. EJNMMI Research 9:1.
Crossref
Crossref
Yuhua Feng, Jinguan Lin, Yiping Liu, Youhong Tang, Yangying Zhou & Meizuo Zhong. (2019)
Investigation of expressions of
PDK
1,
PLK
1 and c‐Myc in diffuse large B‐cell lymphoma
. International Journal of Experimental Pathology 100:1, pages 32-40.
Crossref
Crossref
Chung-Lin Hung, Chih-Ying Ou, Hung-Chih Lai, Yi-Ting Chen, Ching-Chih Lee, Szu-Chin Li & Yu-Chieh Su. (2016) High combined individual and neighborhood socioeconomic status correlated with better survival of patients with lymphoma in post-rituximab era despite universal health coverage. Journal of Cancer Research and Practice 3:4, pages 118-123.
Crossref
Crossref
Penelope Korkolopoulou, Theodoros Vassilakopoulos, Vassilios Milionis & Maria Ioannou. (2016) Recent Advances in Aggressive Large B-cell Lymphomas: A Comprehensive Review. Advances in Anatomic Pathology 23:4, pages 202-243.
Crossref
Crossref
Keisuke Kawamoto, Hiroaki Miyoshi, Noriaki Yoshida, Naoya Nakamura, Koichi Ohshima, Hirohito Sone & Jun Takizawa. (2016)
MYC
translocation and/or BCL 2 protein expression are associated with poor prognosis in diffuse large B‐cell lymphoma
. Cancer Science 107:6, pages 853-861.
Crossref
Crossref
Vicki A. Morrison, Paul Hamlin, Pierre Soubeyran, Reinhard Stauder, Punit Wadhwa, Matti Aapro & Stuart Lichtman. (2015) Diffuse large B-cell lymphoma in the elderly: Impact of prognosis, comorbidities, geriatric assessment, and supportive care on clinical practice. An International Society of Geriatric Oncology (SIOG) Expert Position Paper. Journal of Geriatric Oncology 6:2, pages 141-152.
Crossref
Crossref
Ulla Rüetschi, Martin Stenson, Sverker Hasselblom, Herman Nilsson-Ehle, Ulrika Hansson, Henrik Fagman & Per-Ola Andersson. (2015) SILAC-Based Quantitative Proteomic Analysis of Diffuse Large B-Cell Lymphoma Patients. International Journal of Proteomics 2015, pages 1-12.
Crossref
Crossref
J. H. Park, D. H. Yoon, D. Y. Kim, S. Kim, S. Seo, Y. Jeong, S. W. Lee, C. S. Park, J. Huh & C. Suh. (2014) The highest prognostic impact of LDH among International Prognostic Indices (IPIs): an explorative study of five IPI factors among patients with DLBCL in the era of rituximab. Annals of Hematology 93:10, pages 1755-1764.
Crossref
Crossref
Mary J. Ninan, Ajay Rawal, Hector Mesa, Dennis J. Knapp, Michael A. Kuskowski & Pankaj Gupta. (2013) Expression and phosphorylation of translation regulatory protein 4E-binding protein (BP)-1 in low-risk diffuse large B cell lymphoma. Journal of Hematopathology 6:3, pages 121-126.
Crossref
Crossref
Kun-Ming Chung, Sheng-Tsung Chang, Wen-Tsung Huang, Chin-Li Lu, Hung-Chang Wu, Wei-Shou Hwang, Kwang-Yu Chang & Shih-Sung Chuang. (2013) Bcl-6 expression and lactate dehydrogenase level predict prognosis of primary gastric diffuse large B-cell lymphoma. Journal of the Formosan Medical Association 112:7, pages 382-389.
Crossref
Crossref
Gustav Hedström, Ulf Thunberg, Mattias Berglund, Martin Simonsson, Rose-Marie Amini & Gunilla Enblad. (2013) Low expression of microRNA-129-5p predicts poor clinical outcome in diffuse large B cell lymphoma (DLBCL). International Journal of Hematology 97:4, pages 465-471.
Crossref
Crossref
Ulf Thunberg. (2012) High expression of microRNA-200c predicts poor clinical outcome in diffuse large B-cell lymphoma. Oncology Reports.
Crossref
Crossref
Laurie H. Sehn. (2012) Paramount prognostic factors that guide therapeutic strategies in diffuse large B-cell lymphoma. Hematology 2012:1, pages 402-409.
Crossref
Crossref
Ying Huang, Sheng Ye, Yabing Cao, Zhiming Li, Jiajia Huang, He Huang, Muyan Cai, Rongzhen Luo & Tongyu Lin. (2012) Outcome of R-CHOP or CHOP Regimen for Germinal Center and Nongerminal Center Subtypes of Diffuse Large B-Cell Lymphoma of Chinese Patients. The Scientific World Journal 2012, pages 1-7.
Crossref
Crossref
Venu K. Thirukonda & Adam M. Petrich. (2012) Treatment of Diffuse Large B-cell Lymphoma. Pathology Case Reviews 17:2, pages 90-97.
Crossref
Crossref
Mi-Ae Lyu, Yu (Joshua) Cao, Khalid A. Mohamedali & Michael G. Rosenblum. 2012. Protein Engineering for Therapeutics, Part A. Protein Engineering for Therapeutics, Part A
167
214
.